Subscribe to RSS
DOI: 10.1055/s-0043-1768487
The Impact of Phenobarbital on the Ability of Electroencephalogram to Predict Adverse Outcome in Asphyxiated Neonates during Therapeutic Hypothermia
Funding None.

Abstract
Objective Classification of electroencephalogram (EEG) background has been established to predict outcome in neonates with hypoxic ischemic encephalopathy (HIE). However, the impact of phenobarbital therapy on the predictability of EEG background has not been studied. Our objective is to determine if EEG background after treatment with phenobarbital during therapeutic hypothermia (TH) remains a good predictor for brain injury in neonates with HIE.
Study Design This is a single-center, retrospective study of consecutive neonates with HIE who underwent TH and EEG monitoring from October 2017 to March 2021. Per institutional protocol, all infants received a dose of prophylactic phenobarbital and bumetanide therapy at the onset of TH for sedative and neuroprotective measures. The initial 3 hours of EEG background activity was classified based on national guidelines. Infants were separated into two groups based on EEG background scores: group 1 (normal–mild, n = 30) and group 2 (moderate–severe, n = 36). Brain magnetic resonance imaging (MRI) results were scored based on the National Institute of Child Health and Human Development (NICHD) criteria. Adverse outcomes were defined as death before MRI or NICHD brain injury score > 1A.
Results Infants in group 2 had lower Apgar scores at 5 minutes of age, severe acidemia, moderate to severe encephalopathy score, and earlier initiation of EEG monitoring than infants in group 1. Moderate to severe EEG background score was associated with presence of brain injury on MRI or death (p = 0.003), and this association remained significant even after adjustment for independent risk factors (odds ratio = 56.24 [95% confidence interval = 1.841–1718], p = 0.021).
Conclusion Phenobarbital therapy does not affect the ability of EEG to predict adverse outcome in infants with perinatal asphyxia during TH.
Key Points
-
EEG has a clinical utility for predicting outcome in neonates with hypoxia–ischemia.
-
Phenobarbital therapy is commonly used in neonates, and may impact EEG background findings.
-
In spite phenobarbital therapy, moderate to severe EEG background abnormalities in infants with perinatal asphyxia during TH remain an excellent predictor for poor outcome.
Keywords
hypoxic ischemic encephalopathy - therapeutic hypothermia - phenobarbital - EEG background - brain injuryAuthors' Contributions
A.Y.: conception and design of the study, data collection, interpretation of data, and draft of the manuscript; M.Z.: data statistical analysis, tables and figure, interpretation of data, reviewed and revised the manuscript; P.M.: providing the patient cohort data, reviewed and revised the manuscript.
Note
The earlier version of this manuscript has been presented as a poster presentation at the AES Annual Meeting 2021 in Chicago, at December 5, 2021.
Publication History
Received: 25 July 2022
Accepted: 23 March 2023
Article published online:
26 April 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Northington FJ, Chavez-Valdez R, Martin LJ. Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol 2011; 69 (05) 743-758
- 2 Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010; 86 (06) 329-338
- 3 Yates HL, McCullough S, Harrison C, Gill AB. Hypoxic ischaemic encephalopathy: accuracy of the reported incidence. Arch Dis Child Fetal Neonatal Ed 2012; 97 (01) F77-F78
- 4 Allen KA, Brandon DH. Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments. Newborn Infant Nurs Rev 2011; 11 (03) 125-133
- 5 O'Mara K, McPherson C. Neuroprotective agents for neonates with hypoxic-ischemic encephalopathy. Neonatal Netw 2021; 40 (06) 406-413
- 6 Biagioni E, Mercuri E, Rutherford M. et al. Combined use of electroencephalogram and magnetic resonance imaging in full-term neonates with acute encephalopathy. Pediatrics 2001; 107 (03) 461-468
- 7 Weeke LC, Boylan GB, Pressler RM. et al; NEonatal seizure treatment with Medication Off -patent (NEMO)consortium. Role of EEG background activity, seizure burden and MRI in predicting neurodevelopmental outcome in full-term infants with hypoxic-ischaemic encephalopathy in the era of therapeutic hypothermia. Eur J Paediatr Neurol 2016; 20 (06) 855-864
- 8 Liu Y, Shangguan Y, Barks JD, Silverstein FS. Bumetanide augments the neuroprotective efficacy of phenobarbital plus hypothermia in a neonatal hypoxia-ischemia model. Pediatr Res 2012; 71 (05) 559-565
- 9 Natarajan G, Shankaran S, Laptook AR. et al; NICHD Neonatal Research Network (NRN) Whole Body Hypothermia Subcommittee. Association between sedation-analgesia and neurodevelopment outcomes in neonatal hypoxic-ischemic encephalopathy. J Perinatol 2018; 38 (08) 1060-1067
- 10 Barks JD, Liu YQ, Shangguan Y, Silverstein FS. Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010; 67 (05) 532-537
- 11 Hall RT, Hall FK, Daily DK. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr 1998; 132 (02) 345-348
- 12 Shankaran S, Laptook AR, Ehrenkranz RA. et al; National Institute of Child Health and Human Development Neonatal Research Network. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353 (15) 1574-1584
- 13 Murray DM, Boylan GB, Ryan CA, Connolly S. Early EEG findings in hypoxic-ischemic encephalopathy predict outcomes at 2 years. Pediatrics 2009; 124 (03) e459-e467
- 14 Murray DM, O'Connor CM, Ryan CA, Korotchikova I, Boylan GB. Early EEG grade and outcome at 5 years after mild neonatal hypoxic ischemic encephalopathy. Pediatrics 2016; 138 (04) e20160659
- 15 Tsuchida TN, Wusthoff CJ, Shellhaas RA. et al; American Clinical Neurophysiology Society Critical Care Monitoring Committee. American Clinical Neurophysiology Society standardized EEG terminology and categorization for the description of continuous EEG monitoring in neonates: report of the American Clinical Neurophysiology Society critical care monitoring committee. J Clin Neurophysiol 2013; 30 (02) 161-173
- 16 Clancy RR, Legido A. The exact ictal and interictal duration of electroencephalographic neonatal seizures. Epilepsia 1987; 28 (05) 537-541
- 17 Shankaran S, Barnes PD, Hintz SR. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Brain injury following trial of hypothermia for neonatal hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 2012; 97 (06) F398-F404 [published correction appears in Arch Dis Child Fetal Neonatal Ed. 2014 Mar;99(3):301]
- 18 Dunne JM, Wertheim D, Clarke P. et al. Automated electroencephalographic discontinuity in cooled newborns predicts cerebral MRI and neurodevelopmental outcome. Arch Dis Child Fetal Neonatal Ed 2017; 102 (01) F58-F64
- 19 Deshpande P, Jain A, McNamara PJ. Effect of phenobarbitone on amplitude-integrated electroencephalography in neonates with hypoxic-ischemic encephalopathy during hypothermia. Neonatology 2020; 117 (06) 721-728
- 20 Benedetti GM, Vartanian RJ, McCaffery H, Shellhaas RA. Early electroencephalogram background could guide tailored duration of monitoring for neonatal encephalopathy treated with therapeutic hypothermia. J Pediatr 2020; 221: 81-87 .e1
- 21 Cornet MC, Pasupuleti A, Fang A. et al. Predictive value of early EEG for seizures in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia. Pediatr Res 2018; 84 (03) 399-402
- 22 El-Ayouty M, Abdel-Hady H, El-Mogy S, Zaghlol H, El-Beltagy M, Aly H. Relationship between electroencephalography and magnetic resonance imaging findings after hypoxic-ischemic encephalopathy at term. Am J Perinatol 2007; 24 (08) 467-473
- 23 Ferriero DM. Neonatal brain injury. N Engl J Med 2004; 351 (19) 1985-1995
- 24 Lee YK, Penn A, Patel M, Pandit R, Song D, Ha BY. Hypothermia-treated neonates with hypoxic-ischemic encephalopathy: optimal timing of quantitative ADC measurement to predict disease severity. Neuroradiol J 2017; 30 (01) 28-35
- 25 De Wispelaere LA, Ouwehand S, Olsthoorn M. et al. Electroencephalography and brain magnetic resonance imaging in asphyxia comparing cooled and non-cooled infants. Eur J Paediatr Neurol 2019; 23 (01) 181-190
- 26 Glass HC, Wusthoff CJ, Shellhaas RA. et al. Risk factors for EEG seizures in neonates treated with hypothermia: a multicenter cohort study. Neurology 2014; 82 (14) 1239-1244
- 27 Wusthoff CJ, Dlugos DJ, Gutierrez-Colina A. et al. Electrographic seizures during therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy. J Child Neurol 2011; 26 (06) 724-728
- 28 Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013; 2013 (01) CD003311
- 29 Shah PS. Hypothermia: a systematic review and meta-analysis of clinical trials. Semin Fetal Neonatal Med 2010; 15 (05) 238-246
- 30 McBride MC, Laroia N, Guillet R. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology 2000; 55 (04) 506-513
- 31 Nash KB, Bonifacio SL, Glass HC. et al. Video-EEG monitoring in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. Neurology 2011; 76 (06) 556-562
- 32 Pisani F, Cerminara C, Fusco C, Sisti L. Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome. Neurology 2007; 69 (23) 2177-2185
- 33 Kharoshankaya L, Stevenson NJ, Livingstone V. et al. Seizure burden and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy. Dev Med Child Neurol 2016; 58 (12) 1242-1248
- 34 Soul JS, Bergin AM, Stopp C. et al; Boston Bumetanide Trial Group. A pilot randomized, controlled, double-blind trial of bumetanide to treat neonatal seizures. Ann Neurol 2021; 89 (02) 327-340
- 35 Pressler RM, Boylan GB, Marlow N. et al; NEonatal seizure treatment with Medication Off-patent (NEMO) consortium. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial. Lancet Neurol 2015; 14 (05) 469-477